Areas Examined:
- Pharma compliance issue trends
- The role of EIRs
- When FDA inspections are classified as OAI
- Timing of surveillance inspections following pre-approval inspections
- A case study in contamination failures that led to patient deaths
- The series of events that resulted in a company coming under a consent decree